Post by stcks on Dec 1, 2017 13:33:30 GMT
For all those conspiracy nuts out there here is the way to track Dr. Frost and the jet.
Found this via post on StockTwits.
flightaware.com/live/flight/N3618F
This article was from 2002 when Dr. Frost still was at Ivax:
Frost's jet in SEC filing
The Ivax fee arrangement, which allows for future multimillion-dollar annual payments to PharmAir Corp., was disclosed in a recent SEC filing. Aircraft industry sources put the current market value of a DC-9 between $2 million and $5 million, depending on usage.
lists Frost as PharmAir's sole officer and director. Its principal address is the same address as Ivax, where Frost serves as chairman and CEO.
At least one PharmAir DC-9 jet operates at Fort Lauderdale-Hollywood International Airport, where the company has a leasehold.
"They don't make them [DC-9s] anymore," said Boeing Capital Corp. broker Russ Young, noting that the planes were built between 1965 and 1982. "They just keep improving on the original."
The planes are fully depreciated, Young added. Interior, maintenance, inspection, insurance, fuel and flight crew costs could make Ivax's $2.6 million in payments a real steal or an expensive proposition depending on whether the plane was purchased in good shape, he said.
Ivax communications director Howard Goldman declined comment about how Ivax uses the jet, or if it is rented out to other companies. He confirmed Frost is the beneficial owner of PharmAir.
IVAX's one-paragraph note in the filing does not specify if the price paid for the jet is fair market value or give details on the arrangement.
But Miami shareholder advocate Gunther Karger questions whether the $2 million paid by Ivax is inclusive of crew, maintenance, fuel and operational costs a comparison he terms "wet vs. dry."
"It's these deals related party deals which lead to a lot of questions and problems and now, finally, mistrust," he said. "If Ivax really needs a corporate jet, it would be better placed to lease one from a straight outside leasing company and not from the founder and chairman."
Ivax is one of 12 publicly traded firms in South Florida with revenues of at least $1.2 billion whose certified financial statements were recently requested by the SEC and Congress.
N3618F Aircraft Registration
Aircraft Summary
Summary
2006 AIRBUS A319-115
Fixed wing multi engine
(147 seats / 2 engines)
Owner
PHARMAIR CORP
MIAMI , FL, US
(Corporation)
Airworthiness Class Standard/Transport
Serial Number 2748
Engine CFM INTL CFM56-5B7/P (Turbo-fan) Thrust: 27000lbs
Weight Over 20,000lbs
Speed Not defined
Mode S Code 051011571 / A41379
Registration Details
Status Assigned
Certificate Issue Date 2006-05-11
Airworthiness Date 2007-11-14
Last Action Date 2016-12-21
Expiration 2020-05-31
Registry Source FAA
flightaware.com/resources/registration/N3618F
Found this via post on StockTwits.
flightaware.com/live/flight/N3618F
This article was from 2002 when Dr. Frost still was at Ivax:
Frost's jet in SEC filing
The Ivax fee arrangement, which allows for future multimillion-dollar annual payments to PharmAir Corp., was disclosed in a recent SEC filing. Aircraft industry sources put the current market value of a DC-9 between $2 million and $5 million, depending on usage.
lists Frost as PharmAir's sole officer and director. Its principal address is the same address as Ivax, where Frost serves as chairman and CEO.
At least one PharmAir DC-9 jet operates at Fort Lauderdale-Hollywood International Airport, where the company has a leasehold.
"They don't make them [DC-9s] anymore," said Boeing Capital Corp. broker Russ Young, noting that the planes were built between 1965 and 1982. "They just keep improving on the original."
The planes are fully depreciated, Young added. Interior, maintenance, inspection, insurance, fuel and flight crew costs could make Ivax's $2.6 million in payments a real steal or an expensive proposition depending on whether the plane was purchased in good shape, he said.
Ivax communications director Howard Goldman declined comment about how Ivax uses the jet, or if it is rented out to other companies. He confirmed Frost is the beneficial owner of PharmAir.
IVAX's one-paragraph note in the filing does not specify if the price paid for the jet is fair market value or give details on the arrangement.
But Miami shareholder advocate Gunther Karger questions whether the $2 million paid by Ivax is inclusive of crew, maintenance, fuel and operational costs a comparison he terms "wet vs. dry."
"It's these deals related party deals which lead to a lot of questions and problems and now, finally, mistrust," he said. "If Ivax really needs a corporate jet, it would be better placed to lease one from a straight outside leasing company and not from the founder and chairman."
Ivax is one of 12 publicly traded firms in South Florida with revenues of at least $1.2 billion whose certified financial statements were recently requested by the SEC and Congress.
N3618F Aircraft Registration
Aircraft Summary
Summary
2006 AIRBUS A319-115
Fixed wing multi engine
(147 seats / 2 engines)
Owner
PHARMAIR CORP
MIAMI , FL, US
(Corporation)
Airworthiness Class Standard/Transport
Serial Number 2748
Engine CFM INTL CFM56-5B7/P (Turbo-fan) Thrust: 27000lbs
Weight Over 20,000lbs
Speed Not defined
Mode S Code 051011571 / A41379
Registration Details
Status Assigned
Certificate Issue Date 2006-05-11
Airworthiness Date 2007-11-14
Last Action Date 2016-12-21
Expiration 2020-05-31
Registry Source FAA
flightaware.com/resources/registration/N3618F